172 related articles for article (PubMed ID: 36950498)
1. Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma-A Follow-Up Study.
Alsaleh M; Sithithaworn P; Khuntikeo N; Loilome W; Yongvanit P; Hughes T; O'Connor T; Andrews RH; Wadsworth CA; Williams R; Koomson L; Cox IJ; Holmes E; Taylor-Robinson SD
J Clin Exp Hepatol; 2023; 13(2):203-217. PubMed ID: 36950498
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma.
Alsaleh M; Sithithaworn P; Khuntikeo N; Loilome W; Yongvanit P; Chamadol N; Hughes T; O'Connor T; Andrews RH; Holmes E; Taylor-Robinson SD
J Clin Exp Hepatol; 2019; 9(6):657-675. PubMed ID: 31889746
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort.
Alsaleh M; Leftley Z; Barbera TA; Koomson LK; Zabron A; Crossey MME; Reeves HL; Cramp M; Ryder S; Greer S; Prince M; Sithithaworn P; Shariff M; Khuntikeo N; Loilome W; Yongvanit P; Shen YL; Cox IJ; Williams R; Wadsworth CA; Holmes E; Nash K; Taylor-Robinson SD
J Clin Exp Hepatol; 2020; 10(1):17-29. PubMed ID: 32025163
[TBL] [Abstract][Full Text] [Related]
4.
Treeriya R; Ho PN; Titapun A; Klanrit P; Suksawat M; Kulthawatsiri T; Sirirattanakul S; Loilome W; Namwat N; Wangwiwatsin A; Chamadol N; Khuntikeo N; Phetcharaburanin J
PeerJ; 2023; 11():e15386. PubMed ID: 37187520
[TBL] [Abstract][Full Text] [Related]
5. Roles of liver fluke infection as risk factor for cholangiocarcinoma.
Sithithaworn P; Yongvanit P; Duenngai K; Kiatsopit N; Pairojkul C
J Hepatobiliary Pancreat Sci; 2014 May; 21(5):301-8. PubMed ID: 24408775
[TBL] [Abstract][Full Text] [Related]
6. Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchis viverrini Endemic Settings in Thailand.
Saichua P; Yakovleva A; Kamamia C; Jariwala AR; Sithithaworn J; Sripa B; Brindley PJ; Laha T; Mairiang E; Pairojkul C; Khuntikeo N; Mulvenna J; Sithithaworn P; Bethony JM
PLoS Negl Trop Dis; 2015; 9(7):e0003949. PubMed ID: 26230769
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma.
Saengboonmee C; Seubwai W; Wongkham C; Wongkham S
Cancer Epidemiol; 2015 Jun; 39(3):274-8. PubMed ID: 25910864
[TBL] [Abstract][Full Text] [Related]
8. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry: A Guide for the Clinician.
Alsaleh M; Barbera TA; Andrews RH; Sithithaworn P; Khuntikeo N; Loilome W; Yongvanit P; Cox IJ; Syms RRA; Holmes E; Taylor-Robinson SD
J Clin Exp Hepatol; 2019; 9(5):597-606. PubMed ID: 31695250
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population.
Alsaleh M; Barbera TA; Reeves HL; Cramp ME; Ryder S; Gabra H; Nash K; Shen YL; Holmes E; Williams R; Taylor-Robinson SD
Hepat Med; 2019; 11():47-67. PubMed ID: 31118840
[No Abstract] [Full Text] [Related]
11. Monitoring the Progression of Liver Fluke-Induced Cholangiocarcinoma in a Hamster Model Using Synchrotron FTIR Microspectroscopy and Focal Plane Array Infrared Imaging.
Chatchawal P; Wongwattanakul M; Tippayawat P; Jearanaikoon N; Jumniansong A; Boonmars T; Jearanaikoon P; Wood BR
Anal Chem; 2020 Dec; 92(23):15361-15369. PubMed ID: 33170647
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells.
Kulthawatsiri T; Kittirat Y; Phetcharaburanin J; Tomacha J; Promraksa B; Wangwiwatsin A; Klanrit P; Titapun A; Loilome W; Namwat N
PeerJ; 2023; 11():e16512. PubMed ID: 38025687
[TBL] [Abstract][Full Text] [Related]
13. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
[TBL] [Abstract][Full Text] [Related]
14. A rapid LC-MS/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine disease.
Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():107-117. PubMed ID: 35602306
[TBL] [Abstract][Full Text] [Related]
15. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
16. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
17. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.
Duangkumpha K; Stoll T; Phetcharaburanin J; Yongvanit P; Thanan R; Techasen A; Namwat N; Khuntikeo N; Chamadol N; Roytrakul S; Mulvenna J; Mohamed A; Shah AK; Hill MM; Loilome W
PLoS One; 2019; 14(8):e0221024. PubMed ID: 31425520
[TBL] [Abstract][Full Text] [Related]
18. Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis.
Steele JA; Richter CH; Echaubard P; Saenna P; Stout V; Sithithaworn P; Wilcox BA
Infect Dis Poverty; 2018 May; 7(1):44. PubMed ID: 29769113
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical characteristics and mortality risk between patients with cholangiocarcinoma: A retrospective cohort study.
Liu Y; Wang Y; Yu Y; Luo H; Zhen M; Ren J
Front Surg; 2022; 9():1037310. PubMed ID: 36873806
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
